NEW YORK (GenomeWeb) – Genome analysis firm Igenbio said today it has struck a collaborative agreement with the synthetic biology software design firm Genome Compiler to develop new solutions targeting the synthetic biology community.
The partners will use Chicago-based Igenbio's ERGO genome and analysis discovery system and Genome Compiler's proprietary biology designs solution. ERGO is a web-based platform that integrates functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with other information in the public sphere.
Genome Compiler, based in Los Angeles, provides a software platform for bio-engineering and genomic manipulation tools.
"Partnering with Genome Compiler to create a single integrated platform providing exceptional annotations, pathways, and an enormous curated parts database across all genomes will enable scientists to expedite new product creation," Igenbio's President and CEO Vinayak Kapatral said in a statement.